Abstract:Background: Glucocorticoid plays an important role in the control of carbohydrate metabolism. Patients with Cushing's syndrome have been reported to have an increased incidence of carbohydrate intolerance due to peripheral insulin resistance and hyperinsulinernia, although the exact incidence and nature of this disorder have remained unclear. Few results have been published about insulin resistance and insulin secretion according to the level of glucose concentration, or about the reversibility of such defects in patients with Cushing's syndrome. Methods: To assess the effect of glucocorticoid on the insulin sensitivity and insulin secretion in Cushing's syndrome, 15 patients with Cushing's syndrome were classified into 3 groups (normal glucose tolerance: NGT, impaired glucose tolerance: lGT, diabetes: DM) according to the degree of glucose tolerance based on the oral glucose tolerance test (DGIT). Insulin modified, frequently sampled, intravenous glucose tolerance test (FSlGT) was performed before and after curative surgery on these patients and on 15 healthy control subjects. Data were evaluated by non-parametric statistical analysis. Results: 1) Amoug the 15 patieuts with Cushiug's syudrome, 3 (20%) were NGT, 4 (27%) IGT, and 8 (53%) DM, based on OGTT. Twenty-four hour urinary free cortisol (UFC) was significantly higher in the DM group. 2) Insulin sensitivity index (SI) of Cushing's syndrome was significantly lower than that of the control group (P=0.0024), but was not significantly different among the three Cushing's syudrome groups of NGT, IGT and DM. 3) Glucose mediated glucose disposal (SG) (Edconfirm this abbreviation; it does not seem to match the definition) of Cushing's syndrome was not significantly different from that of the control group. 4) Insulin secretion (AIRg) of Cushing's syndrome tended to be high, but it was not significantly different from that of control. However, according to the level of glucose concentration there was significant difference in AlRg among the three Cushing's syndrome groups (P=0.003l); AIRg of DM was significantly lower than that of NGT. 5) After surgical treatment, parameters of insulin sensitivity and insulin secretion were normalized in 6 cured patients; 1 with NGT, 1 with IGT, and 4 with DM, preoperatively. Median Sl of all 6 patients was significantly improved up to the normal range postoperatively (P=0.0022). Median AIRg of these 6 patients was balanced around that of normal control postoperatively (P=0.0286). Conclusion: Eighty percent of patients with Cushing's syndrome had abnormality of carbohydrate metabolism. Insulin sensitivity was significantly decreased in Cushing's syndrome. Insulin secretion was significantly higher only in the NGT and lGT groups of Cushing's syndrome. As the hypercortisolemia is exacerbated, insulin secretion is significantly decreased and causes DM, suggesting that glucocorticoid has a direct or indirect toxic effect on the pancreatic beta cell.

Metabolic Syndrome in Subclinical Cushing’s Syndrome of Adrenal Incidentaloma

SAT-370 Clinical Characteristics and Metabolic Features of Patients with Subclinical Cushing's Syndrome and Its Correlation with Cortisol Level

Prognosis of Patients with Subclinical Cushing's Syndrome in Adrenal Incidentaloma

[Clinical Features and Outcomes of Surgical Versus Conservative Management in Patients with Subclinical Cushing's Syndrome].

[Metabolic Syndrome in Patients with Adrenocortical Adenoma].

Ectopic ACTH syndrome due to bronchopulmonary carcinoid tumor

Clinical and Biochemical Characteristics of Cushing′s syndrome: A Retrospective Study

Cardiovascular and metabolic risk factors in patients with subclinical Cushing

Clinical Study of Glucose Tolerance with Cushing's Syndrome

Androgens in Cushing's Syndrome

Metabolic Profile Differences in ACTH-dependent and ACTH-independent Cushing Syndrome

Expression of Steroidogenic Enzyme in Subclinical Cushing's Syndrome Due to Adrenal Adenomas

Related Risk Factors of Abnormal Glucose Metabolism in Patients with Cushing's Disease

Clinical features of 131 patients with Cushing syndrome

Impact of cortisol on liver fat and metabolic health in adrenal incidentalomas and Cushing's syndrome

Dysbiosis of gut microbiota and decreased propionic acid associated with metabolic abnormality in Cushing's syndrome

Simultaneous pituitary and adrenal adenomas in a patient with non ACTH dependent Cushing syndrome; a case report with literature review

The Change of Insulin Sensitivity and Insulin Secretion According to Glucose Metabolism Status in Patients with Cushing's Syndrome

Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission

Case Report: Primary Aldosteronism and Subclinical Cushing Syndrome in a 49-Year-old Woman with Hypertension Plus Hypokalaemia.